Internal Medicine Doctors in Ketchikan, AK Accepting Medicare

8 Internal Medicine doctors found. Showing 1 - 8

Michael Sheflo, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-5171

William H Anthes, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3524 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-9830    Fax: 907-225-9840

Dr. Seong J Noh, M.D., PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-5171    Fax: 907-228-8335

Peter E Rice, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-4104    Fax: 907-225-7215

Cheryl Ann Collier-brown, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 212 Carlanna Lake Rd Ste 100, Ketchikan, AK 99901 Phone: 907-228-8140

Dr. Stacy Norman Schulz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 212 Carlanna Lake Rd Ste 201, Box 6755, Ketchikan, AK 99901 Phone: 907-247-3301    Fax: 907-247-3306

Dr. Ahmad I Shafi, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900    Fax: 800-852-3264

Dr. Gregg Mcneil, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-8140    Fax: 907-228-8440

News Archive

PharmaTelevision launches major new services to meet growing demands of pharmaceutical industry

PharmaTelevision Ltd announced today the launch of major new services to meet the growing demand for the production and dissemination of rich media content in the pharmaceutical and biotechnology sector. The company, a subsidiary of PharmaVentures, already provides the only online television channel dedicated to the bio-pharma industry, offering daily television news, analysis and feature interviews.

'Conflict of Interest and Scientific Discovery' symposium to be held at Penn's Perelman School of Medicine

How can academic medical centers best manage the emerging issue of conflict of interest among scientists and physicians working to develop the next generation of treatments and cures? How do academic conflict of interest policies affect the process of scientific discovery?

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

Precision Therapeutics, Inc., a life science company that develops personalized medicine products for individualizing cancer care, today announced that a clinical study which demonstrates the feasibility of the ChemoFx chemoresponse assay to identify patients unlikely to respond to first-line therapy has been accepted for presentation at the 2013 Annual Meeting of the Western Association of Gynecologic Oncologists.

Effective defense against HIV: Acne drug minocycline

Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively targets infected immune cells in which HIV, the virus that causes AIDS, lies dormant and prevents them from reactivating and replicating.

NanoString receives license from Health Canada to market Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has received a Class III Medical Device License from Health Canada, clearing the company to market its Prosigna Breast Cancer Prognostic Gene Signature Assay for assessing a woman's 10-year risk of distant recurrence and accurately identifying the intrinsic biologic subtype of the tumor.

Read more Medical News

› Verified 3 days ago